DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Propranolol for Treatment of Cocaine Addiction - 2

Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders

Intervention: Propranolol (Drug)

Phase: Phase 2

Status: Active, not recruiting

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Kyle Kampman, M.D., Principal Investigator, Affiliation: University of Pennsylvania

Summary

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Clinical Details

Official title: Propranolol for Treatment of Cocaine Addiction

Study design: Treatment

Primary outcome:

Side effects

Cocaine use

Cocaine withdrawal

Cocaine craving

Mood and anxiety

Clinical improvement

Eligibility

Minimum age: 25 Years. Maximum age: 49 Years. Gender(s): Both.

Criteria:

Please contact site for information.

Locations and Contacts

University of Pennsylvania, Philadelphia, Pennsylvania 19104 6178, United States
Additional Information

Starting date: January 1987
Last updated: August 16, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014